Century Therapeutics, Inc.

IPSC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001850119

Price chart

Open-market purchases and sales by IPSC insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Sep 15, 20266:25 PM ETSep 14, 2026Russotti GregorySee RemarksSSaleCommon Stock−2.59K$1.93−$4.99K509.2K−0.5%SEC
Sep 15, 20266:25 PM ETSep 14, 2026Carr DouglasSVP Finance & OperationsSSaleCommon Stock−1.66K$1.93−$3.2K502.91K−0.3%SEC
Sep 9, 20264:35 PM ETSep 8, 2026Russotti GregorySee RemarksSSaleCommon Stock−534$2.05−$1.09K511.79K−0.1%SEC
Sep 9, 20264:34 PM ETSep 8, 2026Carr DouglasSVP Finance & OperationsSSaleCommon Stock−254$2.05−$520.7504.57K−0.1%SEC
Aug 5, 20264:08 PM ETAug 3, 2026Carr DouglasSVP Finance & OperationsSSaleCommon Stock−275$1.977−$543.68504.82K−0.1%SEC

The largest institutional positions in IPSC at the end of Q2 2026.

Institutions holding IPSC in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
RA CAPITAL MANAGEMENT, L.P.17,754,430$43.5M0.38%00.0%Unchanged
TCG Crossover Management, LLC17,754,430$43.4M1.04%00.0%Unchanged
Versant Venture Management, LLC12,166,109$29.81M18.33%00.0%Unchanged
Deep Track Capital, LP9,462,645$23.18M0.34%−25,100−0.3%Reduced
RTW INVESTMENTS, LP8,695,652$21.3M0.18%00.0%Unchanged